Kristian Helin

About

Kristian Helin is a Professor and the CEO at The Institute of Cancer Research in the UK. His research focuses on cancer biology, particularly in the regulation of gene expression and chromatin modifications. Recent publications include studies on the roles of EZH2 and DOT1L in B-cell lymphoma, along with investigations into the HUSH complex and its implications in transcriptional silencing and disease. He is also involved in exploring the mechanisms of hematopoiesis and their relevance to intestinal epithelial maturation.